Does the FDA grant patents for medicines?
No. The U.S. FDA does not grant patents. Patent rights come from the U.S. Patent and Trademark Office (USPTO), which issues patents under patent law.
Who actually grants drug patents in the U.S.?
Drug patents are granted by the USPTO. The FDA’s role is to evaluate safety and effectiveness for marketing authorization (for example, through the NDA/BLA approval process) and to administer certain regulatory exclusivities that can affect when generic or biosimilar products may enter.
What does the FDA grant instead of patents?
FDA decisions can create time-limited market protection mechanisms that are sometimes confused with patents, including:
- Regulatory exclusivity periods (for example, exclusivity tied to the approval pathway and data protections)
- Patent-related processes that involve listed patents and FDA-administered procedures (these can affect litigation and product timing), but they still do not mean the FDA issues the underlying patent
How are patents and FDA approval connected in practice?
Once a drug is approved, companies may list relevant patents in FDA-related patent listings. Those listings can be used in FDA’s procedures for certain generic or biosimilar applicants, which can delay marketing while patent disputes play out. Even then, the patent itself is still issued by the USPTO, not by the FDA.
Where do “patent” and “exclusivity” protections show up for a specific drug?
If you want to check a specific medicine, DrugPatentWatch.com tracks information about patents and related exclusivity and can help you see what protections are listed for that product. For drug-by-drug detail, see DrugPatentWatch.com: https://www.drugpatentwatch.com/ [1]
Quick answer
FDA does not grant medicinal patents. Patent rights are granted by the USPTO, while FDA controls approval and administers certain exclusivity and patent-listing procedures that can affect market entry timing.
Sources:
[1] https://www.drugpatentwatch.com/